Related Experiment Video
Updated: Aug 14, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Analysis of cell cycle regulator proteins in non-small cell lung cancer
V Esposito1, A Baldi, G Tonini
1Third Division of Infective Diseases, D. Cotugno Hospital, Naples 80100, Italy.
Background/Aims:
Abnormalities of the proteins involved in cell cycle checkpoints are extremely common among almost all neoplasms. This study aimed to investigate the expression of four components of the cell cycle machinery-p21, p16, p53, and proliferating cell nuclear antigen (PCNA)-in non-small cell lung cancer (NSCLC).
Methods:
The expression of p21, p16, p53, and PCNA was examined in 68 well characterised NSCLC specimens using immunohistochemistry. The coregulation of these proteins and their influence on survival were analysed using both univariate and multivariate analyses.
Results:
By univariate analysis, the expression of all the proteins examined, except for PCNA, was significantly correlated with survival. In multivariate analysis, the only immunohistochemical parameter able to influence overall survival was p16, confirming the hypothesis that the RB-p16 tumour suppressor pathway is inactivated in most lung cancer samples. Finally, the group of patients with NSCLC who were negative for both p21 and p16 had a significantly shorter overall survival.
Conclusions:
These results suggest that loss of control of cell cycle checkpoints is a common occurrence in lung cancers, and support the idea that functional cooperation between different cell cycle inhibitor proteins constitutes another level of regulation in cell growth control and tumour suppression.
Insights
Cell cycle regulators p21, p16, and p53 are frequently altered in non-small cell lung cancer (NSCLC). Loss of p16 significantly impacts survival, indicating RB-p16 pathway inactivation in lung tumors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cell cycle checkpoint abnormalities are hallmarks of cancer.
- Investigating cell cycle proteins is crucial for understanding tumorigenesis.
Purpose of the Study:
- To examine the expression of p21, p16, p53, and PCNA in non-small cell lung cancer (NSCLC).
- To analyze the coregulation of these proteins and their impact on patient survival.
Main Methods:
- Immunohistochemistry was used to assess protein expression in 68 NSCLC specimens.
- Univariate and multivariate analyses were performed to evaluate survival correlations.
Main Results:
- p21, p16, and p53 expression, but not PCNA, correlated with survival in univariate analysis.
- p16 was the sole significant predictor of overall survival in multivariate analysis, supporting RB-p16 pathway inactivation.
- Patients negative for both p21 and p16 exhibited significantly shorter overall survival.
Conclusions:
- Loss of cell cycle checkpoint control is prevalent in lung cancers.
- Functional cooperation among cell cycle inhibitors is vital for tumor suppression.
- These findings highlight potential therapeutic targets in NSCLC.
Related Concept Videos
Positive Regulator Molecules
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

